DEVICE AND METHODS FOR CALIBRATING ANALYTE SENSORS
First Claim
1. A method of calibrating an analyte sensor, the method comprising:
- providing a vessel containing a first solution, wherein a sensing region of the sensor is in contact with said first solution;
obtaining a first calibration signal from the sensor;
adding an amount of a second solution into said vessel by means of a syringe, whereupon said sensor produces another calibration signal; and
calculating a calibration factor using said first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor.
2 Assignments
0 Petitions

Accused Products

Abstract
The present invention relates to methods and systems for multipoint calibration of an analyte sensor. More specifically, the methods can be used to calibrate glucose sensors.
557 Citations
Transcutaneous analyte sensor | ||
Patent #
US 7,885,697 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optimized sensor geometry for an implantable glucose sensor | ||
Patent #
US 7,881,763 B2
Filed 05/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 7,899,511 B2
Filed 01/17/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SENSORS WITH THROMBORESISTANT COATING | ||
Patent #
US 20110077477A1
Filed 09/30/2010
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Transcutaneous analyte sensor | ||
Patent #
US 7,905,833 B2
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 7,901,354 B2
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,946,984 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
METHODS OF CALIBRATING A SENSOR IN A PATIENT MONITORING SYSTEM | ||
Patent #
US 20110120206A1
Filed 02/19/2009
|
Current Assignee
Sphere Medical Limited
|
Original Assignee
Sphere Medical Limited
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110137601A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 7,949,381 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110124997A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 7,920,906 B2
Filed 03/09/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110118579A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110130971A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110118580A1
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 7,927,274 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20110130970A1
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,010,174 B2
Filed 08/22/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231141A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
MEASUREMENT DEVICES AND METHODS FOR MEASURING ANALYTE CONCENTRATION INCORPORATING TEMPERATURE AND PH CORRECTION | ||
Patent #
US 20110224516A1
Filed 03/11/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231140A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 7,998,071 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Self Contained In-Vitro Diagnostic Device | ||
Patent #
US 20110230743A1
Filed 03/22/2011
|
Current Assignee
Impak Health LLC
|
Original Assignee
Impak Health LLC
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,005,524 B2
Filed 03/24/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20110231107A1
Filed 05/26/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 7,976,492 B2
Filed 08/06/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20110231142A1
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,052,601 B2
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 8,060,174 B2
Filed 04/14/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,060,173 B2
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100179408A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
DUAL ELECTRODE SYSTEM FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100185070A1
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100030053A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100030038A1
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100016687A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION | ||
Patent #
US 20100168546A1
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 7,792,562 B2
Filed 12/22/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20100041971A1
Filed 10/29/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 7,771,352 B2
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168657A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION | ||
Patent #
US 20100168545A1
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217557A1
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100240975A1
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100016698A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
COMPOSITE MATERIAL FOR IMPLANTABLE DEVICE | ||
Patent #
US 20100049024A1
Filed 10/30/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010324A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100191082A1
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 7,831,287 B2
Filed 04/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
OXYGEN ENHANCING MEMBRANE SYSTEMS FOR IMPLANTABLE DEVICES | ||
Patent #
US 20100145172A1
Filed 01/15/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168543A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,826,981 B2
Filed 01/18/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100217555A1
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100174163A1
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100185075A1
Filed 03/29/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168542A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 7,797,028 B2
Filed 04/14/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100331655A1
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS | ||
Patent #
US 20100099970A1
Filed 12/22/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168541A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100268047A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010332A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100010331A1
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036215A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100036224A1
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DecCom Inc.
|
PARTICLE-CONTAINING MEMBRANE AND PARTICULATE ELECTRODE FOR ANALYTE SENSORS | ||
Patent #
US 20100076283A1
Filed 09/17/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168544A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION | ||
Patent #
US 20100179402A1
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100179401A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20100168540A1
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100179400A1
Filed 03/24/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20100185069A1
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20100179409A1
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100198036A1
Filed 04/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 7,783,333 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20100198035A1
Filed 04/14/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20100274111A1
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
OPTICAL DETERMINATION OF PH AND GLUCOSE | ||
Patent #
US 20100274110A1
Filed 07/02/2010
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
POLYMER MEMBRANES FOR CONTINUOUS ANALYTE SENSORS | ||
Patent #
US 20100274107A1
Filed 03/05/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 7,828,728 B2
Filed 02/14/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 7,857,760 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20090030294A1
Filed 10/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20090012379A1
Filed 08/20/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043542A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043541A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043182A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043525A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090043181A1
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SENSOR HEAD FOR USE WITH IMPLANTABLE DEVICES | ||
Patent #
US 20090045055A1
Filed 10/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090062635A1
Filed 11/03/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20090062633A1
Filed 11/04/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DEXCORN INC.
|
DUAL ELECTRODE SYSTEM FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090099436A1
Filed 12/15/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20090124877A1
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090143659A1
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090156919A1
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090143660A1
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20090163790A1
Filed 01/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA | ||
Patent #
US 20090192380A1
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090187088A1
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA | ||
Patent #
US 20090192745A1
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090177064A1
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20090216101A1
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090203981A1
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
POLYMER MEMBRANES FOR CONTINUOUS ANALYTE SENSORS | ||
Patent #
US 20090247856A1
Filed 03/27/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20090242399A1
Filed 03/25/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20090299162A1
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20080033271A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEMS AND METHODS FOR REPLACING SIGNAL DATA ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM | ||
Patent #
US 20080033254A1
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20080091096A1
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
DUAL ELECTRODE SYSTEM FOR A CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080083617A1
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device And Methods Of Use | ||
Patent #
US 20080086039A1
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080183399A1
Filed 04/04/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080188731A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080189051A1
Filed 04/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
LOW OXYGEN IN VIVO ANALYTE SENSOR | ||
Patent #
US 20080208025A1
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS MEDICAL DEVICE WITH VARIABLE STIFFNESS | ||
Patent #
US 20080194938A1
Filed 04/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
BIOINTERFACE WITH MACRO- AND MICRO-ARCHITECTURE | ||
Patent #
US 20080195232A1
Filed 04/15/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20080214915A1
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080287764A1
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
LOW OXYGEN IN VIVO ANALYTE SENSOR | ||
Patent #
US 20080296155A1
Filed 05/01/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR | ||
Patent #
US 20080306435A1
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 20070016381A1
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 20070032706A1
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20070038044A1
Filed 06/03/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20070173708A9
Filed 06/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20070197889A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
ANALYTE SENSOR | ||
Patent #
US 20070197890A1
Filed 02/14/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070191699A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203411A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070179370A1
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070203410A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte Monitoring Device and Methods of Use | ||
Patent #
US 20070208247A1
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070244380A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249919A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
ANALYTE MONITORING DEVICE AND METHODS OF USE | ||
Patent #
US 20070249920A1
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 20060015024A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060020186A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036144A1
Filed 06/21/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036143A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
TRANSCUTANEOUS ANALYTE SENSOR | ||
Patent #
US 20060036142A1
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060142651A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 20060155180A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20060189863A1
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 20060183985A1
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 20060257996A1
Filed 04/14/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Cellulosic-based resistance domain for an analyte sensor | ||
Patent #
US 20060253012A1
Filed 04/28/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 20050027180A1
Filed 08/01/2003
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SYSTEM AND METHOD FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20050187720A1
Filed 01/18/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IMPLANTABLE ANALYTE SENSOR | ||
Patent #
US 20050242479A1
Filed 05/03/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 20040171921A1
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,519 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,073,520 B2
Filed 05/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Porous membranes for use with implantable devices | ||
Patent #
US 8,118,877 B2
Filed 01/17/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,128,562 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,133,178 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,150,488 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,155,723 B2
Filed 01/28/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,160,671 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,162,829 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,167,801 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,175,673 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,177,716 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,195,265 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,206,297 B2
Filed 12/16/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,216,139 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,224,413 B2
Filed 10/10/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,558 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,557 B2
Filed 12/28/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,226,555 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,229,536 B2
Filed 05/27/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,231,531 B2
Filed 06/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,231,532 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,233,959 B2
Filed 09/01/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,233,958 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,235,896 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,249,684 B2
Filed 09/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,251,906 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 8,255,032 B2
Filed 01/15/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 8,255,030 B2
Filed 04/25/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,255,031 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 8,255,033 B2
Filed 04/25/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,257,259 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,260,392 B2
Filed 06/09/2008
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal data artifacts in a glucose sensor data stream | ||
Patent #
US 8,260,393 B2
Filed 06/13/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,265,726 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,265,725 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,273,022 B2
Filed 02/13/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,275,439 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Implantable analyte sensor | ||
Patent #
US 8,277,713 B2
Filed 05/03/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 8,282,550 B2
Filed 07/29/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,282,549 B2
Filed 12/08/2004
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,287,454 B2
Filed 09/27/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,287,453 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,290,561 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,292,810 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,306,598 B2
Filed 11/09/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,311,749 B2
Filed 05/26/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,321,149 B2
Filed 06/29/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,336 B2
Filed 03/18/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,346,337 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,346,338 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,353,829 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,357,091 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,366,614 B2
Filed 03/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 8,369,919 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,372,005 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,374,667 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,380,273 B2
Filed 04/11/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,386,004 B2
Filed 09/07/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,391,945 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,394,021 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,409,131 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,412,301 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor Calibration | ||
Patent #
US 20130083820A1
Filed 11/27/2012
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Lightship Medical Limited
|
Systems and methods for processing sensor data | ||
Patent #
US 8,423,113 B2
Filed 10/24/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 8,423,114 B2
Filed 10/01/2007
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration techniques for a continuous analyte sensor | ||
Patent #
US 8,428,678 B2
Filed 05/16/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,435,179 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,442,610 B2
Filed 08/21/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,457,708 B2
Filed 12/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,460,231 B2
Filed 07/11/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,465,425 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,469,886 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,473,021 B2
Filed 07/31/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Measurement devices and methods for measuring analyte concentration incorporating temperature and pH correction | ||
Patent #
US 8,473,222 B2
Filed 03/11/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,480,580 B2
Filed 04/19/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,483,791 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,491,474 B2
Filed 01/27/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optical determination of pH and glucose | ||
Patent #
US 8,498,682 B2
Filed 07/02/2010
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Sensor head for use with implantable devices | ||
Patent #
US 8,509,871 B2
Filed 10/28/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,515,519 B2
Filed 02/26/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,527,025 B1
Filed 11/22/1999
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,527,026 B2
Filed 03/02/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Use of an equilibrium intravascular sensor to achieve tight glycemic control | ||
Patent #
US 8,535,262 B2
Filed 12/09/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,548,553 B2
Filed 06/22/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Particle-containing membrane and particulate electrode for analyte sensors | ||
Patent #
US 8,560,039 B2
Filed 09/17/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,560,037 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
BIOLOGICAL INFORMATION MONITORING APPARATUS | ||
Patent #
US 20130274617A1
Filed 04/15/2013
|
Current Assignee
Nihon Kohden Corporation
|
Original Assignee
Nihon Kohden Corporation
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,562,558 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,579,816 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 8,583,204 B2
Filed 03/05/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,597,189 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensor calibration | ||
Patent #
US 8,607,612 B2
Filed 11/27/2012
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Lightship Medical Limited
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,612,159 B2
Filed 02/16/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte sensor | ||
Patent #
US 8,615,282 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 8,611,978 B2
Filed 01/07/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,617,071 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,622,905 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,622,906 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,641,619 B2
Filed 12/21/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,649,841 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,652,043 B2
Filed 07/20/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,657,745 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,657,747 B2
Filed 04/05/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,660,627 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,663,109 B2
Filed 03/29/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,666,469 B2
Filed 11/16/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,668,645 B2
Filed 01/03/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,670,815 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,672,844 B2
Filed 02/27/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for processing analyte sensor data | ||
Patent #
US 8,672,845 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Self contained in-vitro diagnostic device | ||
Patent #
US 8,673,214 B2
Filed 03/22/2011
|
Current Assignee
Impak Health LLC
|
Original Assignee
Impak Health LLC
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,676,287 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,676,288 B2
Filed 06/22/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Biosensor Calibration Method | ||
Patent #
US 20140080167A1
Filed 03/14/2013
|
Current Assignee
Tanita Corporation
|
Original Assignee
Tanita Corporation
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 8,682,408 B2
Filed 03/05/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,688,188 B2
Filed 06/30/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,690,775 B2
Filed 04/11/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optical sensor configuration for ratiometric correction of glucose measurement | ||
Patent #
US 8,700,115 B2
Filed 05/15/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,700,117 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensors with thromboresistant coating | ||
Patent #
US 8,715,589 B2
Filed 05/14/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,721,545 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,348 B2
Filed 03/17/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,734,346 B2
Filed 04/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Equilibrium non-consuming fluorescence sensor for real time intravascular glucose measurement | ||
Patent #
US 8,738,107 B2
Filed 05/09/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,738,109 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Cellulosic-based resistance domain for an analyte sensor | ||
Patent #
US 8,744,546 B2
Filed 04/28/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,744,545 B2
Filed 03/03/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Glucose sensor calibration | ||
Patent #
US 8,746,031 B2
Filed 11/16/2011
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Lightship Medical Limited
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,747,315 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,761,856 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,771,187 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,774,888 B2
Filed 01/20/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,774,887 B2
Filed 03/24/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,777,853 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,006 B2
Filed 12/11/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,788,008 B2
Filed 05/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,790,260 B2
Filed 10/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,954 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,955 B2
Filed 06/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,792,953 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,795,177 B2
Filed 01/14/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,801,611 B2
Filed 03/22/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,801,612 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 8,801,610 B2
Filed 07/24/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 8,808,228 B2
Filed 06/05/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 8,808,182 B2
Filed 04/27/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous medical device with variable stiffness | ||
Patent #
US 8,812,072 B2
Filed 04/17/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,812,073 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,821,400 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optical systems and methods for ratiometric measurement of blood glucose concentration | ||
Patent #
US 8,838,195 B2
Filed 02/06/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 8,840,552 B2
Filed 12/08/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,840,553 B2
Filed 02/26/2009
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 8,843,187 B2
Filed 06/01/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods of calibrating a sensor in a patient monitoring system | ||
Patent #
US 8,869,585 B2
Filed 02/19/2009
|
Current Assignee
Sphere Medical Limited
|
Original Assignee
Sphere Medical Limited
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,880,137 B2
Filed 04/18/2003
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,882,741 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,273 B2
Filed 11/07/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 8,886,272 B2
Filed 02/22/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 8,909,314 B2
Filed 07/20/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 8,911,369 B2
Filed 12/15/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 8,915,849 B2
Filed 02/03/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,915,850 B2
Filed 03/28/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibration material delivery devices and methods | ||
Patent #
US 8,919,605 B2
Filed 11/30/2010
|
Current Assignee
Intuity Medical Inc.
|
Original Assignee
Intuity Medical Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,920,319 B2
Filed 12/28/2012
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 8,920,401 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 8,923,947 B2
Filed 07/23/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood Sampling Tube with Integrated Sensor Device | ||
Patent #
US 20150011847A1
Filed 01/22/2013
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Siemens AG
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 8,954,128 B2
Filed 10/18/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 8,974,386 B2
Filed 11/01/2005
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Biosensor calibration method | ||
Patent #
US 8,975,080 B2
Filed 03/14/2013
|
Current Assignee
Tanita Corporation
|
Original Assignee
Tanita Corporation
|
Use of an equilibrium sensor to monitor glucose concentration | ||
Patent #
US 8,979,790 B2
Filed 09/11/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Optical determination of pH and glucose | ||
Patent #
US 8,983,565 B2
Filed 07/25/2013
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,332 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,011,331 B2
Filed 12/29/2004
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,014,773 B2
Filed 03/07/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Calibrator for a sensor | ||
Patent #
US 9,017,622 B2
Filed 11/27/2012
|
Current Assignee
Lightship Medical Limited
|
Original Assignee
Lightship Medical Limited
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,042,953 B2
Filed 03/02/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,044,199 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,050,413 B2
Filed 04/30/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,060,742 B2
Filed 03/19/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,695 B2
Filed 04/12/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,697 B2
Filed 10/27/2011
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,066,694 B2
Filed 04/03/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,072,477 B2
Filed 06/21/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,078,626 B2
Filed 03/31/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,078,607 B2
Filed 06/17/2013
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,078,608 B2
Filed 07/13/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,107,623 B2
Filed 04/15/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,149,219 B2
Filed 02/09/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SENSOR SYSTEMS AND METHODS OF USING THE SAME | ||
Patent #
US 20150282751A1
Filed 10/11/2013
|
Current Assignee
Edwards Lifesciences Corporation
|
Original Assignee
Edwards Lifesciences Corporation
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 9,155,496 B2
Filed 02/18/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,155,843 B2
Filed 07/26/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 9,173,607 B2
Filed 01/30/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 9,173,606 B2
Filed 01/30/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,192,328 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,220,449 B2
Filed 07/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,247,900 B2
Filed 06/04/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,247,901 B2
Filed 08/02/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method of using an absorptive sensor element | ||
Patent #
US 9,279,792 B2
Filed 03/27/2012
|
Current Assignee
3M Innovative Properties Company
|
Original Assignee
3M Innovative Properties Company
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,282,925 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,314,196 B2
Filed 09/07/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,716 B2
Filed 12/05/2014
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 9,328,371 B2
Filed 07/16/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,326,714 B2
Filed 06/29/2010
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 9,339,223 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Particle-containing membrane and particulate electrode for analyte sensors | ||
Patent #
US 9,339,222 B2
Filed 05/31/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,351,668 B2
Filed 10/12/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,364,173 B2
Filed 09/23/2009
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,414,777 B2
Filed 03/10/2005
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,420,965 B2
Filed 07/01/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,420,968 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method of detecting volatile organic compounds | ||
Patent #
US 9,429,537 B2
Filed 04/02/2012
|
Current Assignee
3M Innovative Properties Company
|
Original Assignee
3M Innovative Properties Company
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,427,183 B2
Filed 07/12/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 9,439,589 B2
Filed 11/25/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 9,446,194 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,451,908 B2
Filed 12/19/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Blood sampling tube with integrated sensor device | ||
Patent #
US 9,468,404 B2
Filed 01/22/2013
|
Current Assignee
Siemens Healthcare Diagnostics Incorporated
|
Original Assignee
Siemens AG
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,498,159 B2
Filed 10/30/2007
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,498,155 B2
Filed 10/16/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Vapor sensor including sensor element with integral heating | ||
Patent #
US 9,506,888 B2
Filed 04/04/2012
|
Current Assignee
3M Innovative Properties Company
|
Original Assignee
3M Innovative Properties Company
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 9,504,413 B2
Filed 04/15/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,510,782 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 9,532,741 B2
Filed 07/25/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated receiver for continuous analyte sensor | ||
Patent #
US 9,538,946 B2
Filed 03/25/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 9,549,699 B2
Filed 10/17/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 9,566,026 B2
Filed 10/17/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 9,572,523 B2
Filed 09/22/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 9,579,053 B2
Filed 03/26/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,585,607 B2
Filed 04/04/2012
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 9,597,027 B2
Filed 10/30/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 9,610,034 B2
Filed 11/09/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,610,031 B2
Filed 04/13/2011
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,649,069 B2
Filed 06/29/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Method for identification and quantitative determination of an unknown organic compound in a gaseous medium | ||
Patent #
US 9,658,198 B2
Filed 12/10/2012
|
Current Assignee
3M Innovative Properties Company
|
Original Assignee
3M Innovative Properties Company
|
Analyte sensor | ||
Patent #
US 9,668,677 B2
Filed 10/26/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 9,693,721 B2
Filed 06/17/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
GLUCOSE SENSOR CALIBRATION | ||
Patent #
US 20170202489A1
Filed 02/03/2015
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Lightship Medical Limited
|
Systems and methods for processing sensor data | ||
Patent #
US 9,717,449 B2
Filed 01/15/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,724,028 B2
Filed 11/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,724,045 B1
Filed 04/06/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 9,741,139 B2
Filed 08/09/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Signal processing for continuous analyte sensor | ||
Patent #
US 9,750,441 B2
Filed 08/15/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for replacing signal artifacts in a glucose sensor data stream | ||
Patent #
US 9,750,460 B2
Filed 04/14/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 9,757,061 B2
Filed 09/01/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,775,543 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 9,788,766 B2
Filed 05/19/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,801,572 B2
Filed 06/18/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor head for use with implantable devices | ||
Patent #
US 9,804,114 B2
Filed 03/02/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
IGNITION INTERLOCK BREATHALYZER | ||
Patent #
US 20170313189A1
Filed 04/27/2017
|
Current Assignee
Consumer Safety Technology Incorporated
|
Original Assignee
Consumer Safety Technology Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,814,414 B2
Filed 03/30/2010
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 9,833,143 B2
Filed 06/05/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Optical systems and methods for ratiometric measurement of blood glucose concentration | ||
Patent #
US 9,839,378 B2
Filed 08/07/2014
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
Self contained in-vitro diagnostic device | ||
Patent #
US 9,851,360 B2
Filed 03/14/2014
|
Current Assignee
Impak Health LLC
|
Original Assignee
Impak Health LLC
|
System and methods for processing analyte sensor data | ||
Patent #
US 9,895,089 B2
Filed 05/20/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Calibration material delivery devices and methods | ||
Patent #
US 9,897,610 B2
Filed 12/01/2014
|
Current Assignee
Intuity Medical Inc.
|
Original Assignee
Intuity Medical Inc.
|
Sensor systems and methods of using the same | ||
Patent #
US 9,907,503 B2
Filed 10/11/2013
|
Current Assignee
Edwards Lifesciences Corporation
|
Original Assignee
Edwards Lifesciences Corporation
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 9,918,668 B2
Filed 03/09/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Device and method for determining analyte levels | ||
Patent #
US 9,931,067 B2
Filed 09/13/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated delivery device for continuous glucose sensor | ||
Patent #
US 9,937,293 B2
Filed 08/19/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 9,986,942 B2
Filed 08/10/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 9,993,186 B2
Filed 02/09/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,022,078 B2
Filed 05/23/2006
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Particle-containing membrane and particulate electrode for analyte sensors | ||
Patent #
US 10,028,683 B2
Filed 10/07/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Particle-containing membrane and particulate electrode for analyte sensors | ||
Patent #
US 10,028,684 B2
Filed 09/21/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Membrane for use with implantable devices | ||
Patent #
US 10,039,480 B2
Filed 02/11/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Biological information monitoring apparatus | ||
Patent #
US 10,058,286 B2
Filed 04/15/2013
|
Current Assignee
Nihon Kohden Corporation
|
Original Assignee
Nihon Kohden Corporation
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 10,136,844 B2
Filed 11/18/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Sensor calibration method and apparatus | ||
Patent #
US 10,139,291 B2
Filed 04/07/2014
|
Current Assignee
Sphere Medical Limited
|
Original Assignee
Sphere Medical Limited
|
Polymer membranes for continuous analyte sensors | ||
Patent #
US 10,143,410 B2
Filed 06/01/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Systems and methods for processing sensor data | ||
Patent #
US 10,182,751 B2
Filed 06/26/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,201,301 B2
Filed 04/18/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,231,654 B2
Filed 06/23/2015
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Low oxygen in vivo analyte sensor | ||
Patent #
US 10,265,000 B2
Filed 08/03/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,278,580 B2
Filed 06/09/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Dual electrode system for a continuous analyte sensor | ||
Patent #
US 10,299,712 B2
Filed 09/05/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Cellulosic-based resistance domain for an analyte sensor | ||
Patent #
US 10,300,507 B2
Filed 02/14/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,314,525 B2
Filed 01/06/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,327,638 B2
Filed 10/30/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,349,873 B2
Filed 04/27/2016
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,376,188 B2
Filed 09/21/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated medicament delivery device for use with continuous analyte sensor | ||
Patent #
US 10,403,012 B2
Filed 07/18/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Glucose sensor calibration | ||
Patent #
US 10,433,778 B2
Filed 02/03/2015
|
Current Assignee
Baxter International Inc., Baxter Healthcare SA
|
Original Assignee
Baxter International Inc.
|
Analyte monitoring device and methods of use | ||
Patent #
US 10,478,108 B2
Filed 02/05/2016
|
Current Assignee
Abbott Diabetes Care Incorporated
|
Original Assignee
Abbott Diabetes Care Incorporated
|
Transcutaneous analyte sensor | ||
Patent #
US 10,524,703 B2
Filed 01/24/2014
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,537,678 B2
Filed 12/16/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Particle-containing membrane and particulate electrode for analyte sensors | ||
Patent #
US 10,561,352 B2
Filed 07/03/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,137 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,136 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Oxygen enhancing membrane systems for implantable devices | ||
Patent #
US 10,610,140 B2
Filed 05/11/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,610,135 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for promoting glucose management | ||
Patent #
US 10,610,642 B2
Filed 12/30/2013
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,617,336 B2
Filed 06/28/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,653,835 B2
Filed 10/24/2017
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,667,729 B2
Filed 06/27/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,667,730 B2
Filed 10/16/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Methods and systems for simulating glucose response to simulated actions | ||
Patent #
US 10,675,405 B2
Filed 12/04/2015
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensing biointerface | ||
Patent #
US 10,702,193 B2
Filed 01/14/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,709,364 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,362 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,709,363 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,716,498 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,722,152 B2
Filed 11/05/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,743,801 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data | ||
Patent #
US 10,786,185 B2
Filed 01/05/2018
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,158 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,799,159 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,577 B2
Filed 02/13/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Analyte sensor | ||
Patent #
US 10,813,576 B2
Filed 11/21/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Integrated insulin delivery system with continuous glucose sensor | ||
Patent #
US 10,835,672 B2
Filed 05/05/2020
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
System and methods for processing analyte sensor data for sensor calibration | ||
Patent #
US 10,856,787 B2
Filed 07/31/2019
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
SENSORS WITH THROMBORESISTANT COATING | ||
Patent #
US 20110077477A1
Filed 09/30/2010
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
OPTICAL SENSOR CONFIGURATION FOR RATIOMETRIC CORRECTION OF BLOOD GLUCOSE MEASUREMENT | ||
Patent #
US 20110105866A1
Filed 11/04/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Pyridinium boronic acid quenchers for use in analyte sensors | ||
Patent #
US 7,939,664 B2
Filed 05/01/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
IDENTIFICATION OF ABERRANT MEASUREMENTS OF IN VIVO GLUCOSE CONCENTRATION USING TEMPERATURE | ||
Patent #
US 20110152658A1
Filed 12/17/2010
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
PYRIDINIUM BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | ||
Patent #
US 20110171742A1
Filed 03/22/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
DEPLOYMENT SYSTEM AND METHOD FOR OPTICAL ANALYTE SENSOR | ||
Patent #
US 20110263953A1
Filed 04/27/2011
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Optical determination of ph and glucose | ||
Patent #
US 7,751,863 B2
Filed 02/06/2007
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
OPTICAL DETERMINATION OF PH AND GLUCOSE | ||
Patent #
US 20100274110A1
Filed 07/02/2010
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
EQUILIBRIUM NON-CONSUMING FLUORESCENCE SENSOR FOR REAL TIME INTRAVASCULAR GLUCOSE MEASUREMENT | ||
Patent #
US 20090018418A1
Filed 05/09/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
MASS DEFECT LABELING AND METHODS OF USE THEREOF | ||
Patent #
US 20090061523A1
Filed 08/28/2007
|
Current Assignee
The University of Georgia Research Foundation Inc.
|
Original Assignee
The University of Georgia Research Foundation Inc.
|
POLYVIOLOGEN BORONIC ACID QUENCHERS FOR USE IN ANALYTE SENSORS | ||
Patent #
US 20090081803A1
Filed 07/11/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
USE OF AN EQUILIBRIUM INTRAVASCULAR SENSOR TO ACHIEVE TIGHT GLYCEMIC CONTROL | ||
Patent #
US 20090177143A1
Filed 11/20/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
SENSOR FOR PERCUTANEOUS INTRAVASCULAR DEPLOYMENT WITHOUT AN INDWELLING CANNULA | ||
Patent #
US 20090264719A1
Filed 04/16/2009
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Green and orange fluorescent labels and their uses | ||
Patent #
US 7,317,111 B2
Filed 09/23/2003
|
Current Assignee
Aries Associates Inc.
|
Original Assignee
Aries Associates Inc.
|
Coiled circuit bio-sensor | ||
Patent #
US 20080009687A1
Filed 05/25/2007
|
Current Assignee
Northrop Grumman Systems Corp.
|
Original Assignee
Northrop Grumman Systems Corp.
|
PHOTOELECTRIC CONVERTER AND X-RAY IMAGE PICK-UP DEVICE | ||
Patent #
US 20080001091A1
Filed 08/24/2007
|
Current Assignee
Canon Kabushiki Kaisha
|
Original Assignee
Canon Kabushiki Kaisha
|
FLUORESCENT DYES FOR USE IN GLUCOSE SENSING | ||
Patent #
US 20080027245A1
Filed 07/24/2007
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Device, systems, methods and tools for continuous glucose monitoring | ||
Patent #
US 20080154107A1
Filed 12/20/2006
|
Current Assignee
ArKal Medical Inc.
|
Original Assignee
ArKal Medical Inc.
|
SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA | ||
Patent #
US 20080183061A1
Filed 04/04/2008
|
Current Assignee
DexCom Incorporated
|
Original Assignee
DexCom Incorporated
|
Fluorescent dyes for use in glucose sensing | ||
Patent #
US 7,417,164 B2
Filed 07/24/2007
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
METHOD FOR POLYMERIZING A MONOMER SOLUTION WITHIN A CAVITY TO GENERATE A SMOOTH POLYMER SURFACE | ||
Patent #
US 20080187655A1
Filed 02/05/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
OPTICAL SYSTEMS AND METHODS FOR RATIOMETRIC MEASUREMENT OF BLOOD GLUCOSE CONCENTRATION | ||
Patent #
US 20080188725A1
Filed 02/06/2008
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Medtronic Minimed Incorporated
|
OPTICAL DETERMINATION OF PH AND GLUCOSE | ||
Patent #
US 20080188722A1
Filed 02/06/2007
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GluMetrics Inc.
|
Apparatus and method for measuring myocardial oxygen consumption | ||
Patent #
US 7,181,260 B2
Filed 11/12/2004
|
Current Assignee
Guillermo Gutierrez
|
Original Assignee
Guillermo Gutierrez
|
Apparatus and methods for analyzing body fluid samples | ||
Patent #
US 20070060872A1
Filed 02/13/2006
|
Current Assignee
OptiScan Biomedical Corporation
|
Original Assignee
OptiScan Biomedical Corporation
|
METHOD AND DEVICE FOR MONITORING INFUSIONS | ||
Patent #
US 20070123775A1
Filed 09/19/2006
|
Current Assignee
Dragerwerk AG Company KGaA
|
Original Assignee
Drager Medical AG Co KG
|
Device for setting up a dilution measurement site | ||
Patent #
US 20070175828A1
Filed 01/30/2007
|
Current Assignee
PULSION Medical Systems SE
|
Original Assignee
PULSION Medical Systems SE
|
Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers | ||
Patent #
US 6,766,183 B2
Filed 12/28/2001
|
Current Assignee
Regents of the University of California, Lawrence Livermore National Security LLC
|
Original Assignee
Medtronic Minimed Incorporated, Regents of the University of California
|
Optical pH sensor | ||
Patent #
US 20060088722A1
Filed 10/25/2004
|
Current Assignee
The Research Foundation for The State University of New York
|
Original Assignee
The Research Foundation for The State University of New York
|
Optical determination of glucose utilizing boronic acid adducts | ||
Patent #
US 20060083688A1
Filed 12/07/2005
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Optical pH sensor | ||
Patent #
US 20060105174A1
Filed 10/24/2005
|
Current Assignee
The Research Foundation for The State University of New York
|
Original Assignee
The Research Foundation for The State University of New York
|
Biological interface system with thresholded configuration | ||
Patent #
US 20060195042A1
Filed 12/30/2005
|
Current Assignee
BRAINGATE CO. LLC
|
Original Assignee
BRAINGATE CO. LLC
|
Ratiometric fluorescent pH sensor for non-invasive monitoring | ||
Patent #
US 20050090014A1
Filed 06/30/2003
|
Current Assignee
University of Maryland
|
Original Assignee
University of Maryland
|
Pyrenyloxysulfonic acid fluorescent agents | ||
Patent #
US 20050123935A1
Filed 12/09/2003
|
Current Assignee
Molecular Probes Incorporated
|
Original Assignee
Molecular Probes Incorporated
|
Compositions of matter useful as pH indicators and related methods | ||
Patent #
US 20050233465A1
Filed 04/14/2005
|
Current Assignee
BIOPROCESSORS CORP.
|
Original Assignee
BIOPROCESSORS CORP.
|
Optical determination of glucose utilizing boronic acid adducts | ||
Patent #
US 20040028612A1
Filed 06/05/2003
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Method of making a kink-resistant catheter | ||
Patent #
US 6,702,972 B1
Filed 08/23/2000
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
DIAMETRICS MEDICAL LIMITED
|
Optical-based sensing devices | ||
Patent #
US 6,711,423 B2
Filed 09/27/2001
|
Current Assignee
Senseonics Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
Method and apparatus for analyte sensing | ||
Patent #
US 20040072358A1
Filed 10/03/2003
|
Current Assignee
BioTex Incorporated
|
Original Assignee
BioTex Incorporated
|
Detection of analytes in aqueous environments | ||
Patent #
US 6,794,195 B2
Filed 08/03/2001
|
Current Assignee
Senseonics Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
Detection of biological molecules using chemical amplification and optical sensors | ||
Patent #
US 6,804,544 B2
Filed 08/21/2001
|
Current Assignee
Minimed Inc.
|
Original Assignee
Minimed Inc.
|
Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | ||
Patent #
US 6,800,451 B2
Filed 07/03/2002
|
Current Assignee
Sensors For Medicine and Science Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
Implantable myocardial ischemia detection, indication and action technology | ||
Patent #
US 20030013974A1
Filed 09/15/2002
|
Current Assignee
Infinite Biomedical Technologies LLC
|
Original Assignee
Nitish V. Thakor, Ananth Natarajan
|
Probe | ||
Patent #
US 6,585,665 B1
Filed 03/02/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
DIAMETRICS MEDICAL LIMITED
|
Cranial bolt | ||
Patent #
US 6,623,490 B1
Filed 02/12/2001
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
DIAMETRICS MEDICAL LIMITED
|
Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof | ||
Patent #
US 6,627,177 B2
Filed 12/05/2000
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Polyhydroxyl-substituted organic molecule sensing method and device | ||
Patent #
US 6,653,141 B2
Filed 12/05/2000
|
Current Assignee
Regents of the University of California
|
Original Assignee
Regents of the University of California
|
Optical-based sensing devices | ||
Patent #
US 20020026108A1
Filed 09/27/2001
|
Current Assignee
Senseonics Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
Detection of biological molecules using chemical amplification and optical sensors | ||
Patent #
US 20020018843A1
Filed 08/21/2001
|
Current Assignee
Minimed Inc.
|
Original Assignee
Minimed Inc.
|
Physiological fluid extraction with rapid analysis | ||
Patent #
US 6,375,627 B1
Filed 03/02/2000
|
Current Assignee
Sanofi-Aventis Deutschland GmbH
|
Original Assignee
Agilent Technologies Incorporated
|
Sensor for measuring a bioanalyte such as lactate | ||
Patent #
US 6,464,849 B1
Filed 10/07/1999
|
Current Assignee
Pepex Biomedical Inc.
|
Original Assignee
Pepex Biomedical LLC
|
Process and devices for determining the instant of injection and the duration of injection in thermodilution measurements | ||
Patent #
US 6,200,301 B1
Filed 08/31/1998
|
Current Assignee
Pulsion Medical Systems AG
|
Original Assignee
Pulsion Medical Systems AG
|
Optical-based sensing devices, especially for in-situ sensing in humans | ||
Patent #
US 6,304,766 B1
Filed 08/26/1998
|
Current Assignee
Sensors For Medicine and Science Incorporated
|
Original Assignee
Sensors For Medicine and Science Incorporated
|
Detection of biological molecules using chemical amplification and optical sensors | ||
Patent #
US 6,319,540 B1
Filed 09/22/1999
|
Current Assignee
Minimed Inc.
|
Original Assignee
Minimed Inc.
|
Detection of biological molecules using chemical amplification and optical sensors | ||
Patent #
US 6,011,984 A
Filed 11/21/1996
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Minimed Inc.
|
System and method for measuring a bioanalyte such as lactate | ||
Patent #
US 6,117,290 A
Filed 07/24/1998
|
Current Assignee
RUBICON INVESTMENTS INC.
|
Original Assignee
Pepex Biomedical LLC
|
Optical sensor system for determining pH values and ionic strengths | ||
Patent #
US 5,922,612 A
Filed 01/02/1997
|
Current Assignee
Ciba-Geigy Corporation
|
Original Assignee
Novartis Corporation
|
Point-of-care analyzer module | ||
Patent #
US 5,747,666 A
Filed 03/26/1997
|
Current Assignee
John P. Willis
|
Original Assignee
John P. Willis
|
Boronic acid compound having a binaphthyl group | ||
Patent #
US 5,763,238 A
Filed 12/28/1995
|
Current Assignee
Research Development Corporation Of Japan
|
Original Assignee
Research Development Corporation Of Japan
|
Multi-parameter sensor apparatus | ||
Patent #
US 5,596,988 A
Filed 12/07/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Reduction of discoloration in plastic materials | ||
Patent #
US 5,622,259 A
Filed 06/07/1995
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
DIAMETRICS MEDICAL LIMITED
|
Fluorescent compound suitable for use in the detection of saccharides | ||
Patent #
US 5,503,770 A
Filed 11/07/1994
|
Current Assignee
Research Development Corporation Of Japan
|
Original Assignee
Research Development Corporation Of Japan
|
Solid state sensors | ||
Patent #
US 5,511,547 A
Filed 02/16/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Automatic calibrating apparatus for laboratory ion concentration meter | ||
Patent #
US 5,511,408 A
Filed 07/28/1993
|
Current Assignee
Horiba Limited
|
Original Assignee
Horiba Limited
|
Method and means for detecting polyhydroxyl compounds | ||
Patent #
US 5,512,246 A
Filed 11/17/1993
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Anthony P. Russell
|
Photocleavable derivatives of hydroxyprenesulfonic acids | ||
Patent #
US 5,514,710 A
Filed 01/11/1994
|
Current Assignee
Molecular Probes Incorporated
|
Original Assignee
Molecular Probes Incorporated
|
Fluorescent polymers useful in conjunction with optical PH sensors | ||
Patent #
US 5,536,783 A
Filed 05/30/1995
|
Current Assignee
Optical Sensors Incorporated
|
Original Assignee
Optical Sensors Incorporated
|
Measurement of bladder oxygen | ||
Patent #
US 5,389,217 A
Filed 04/28/1994
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Intravascular catheter with kink resistant tip | ||
Patent #
US 5,279,596 A
Filed 06/25/1992
|
Current Assignee
Cordis Corporation
|
Original Assignee
Cordis Corporation
|
Assembly of a tube and a part and apparatus and method of manufacture | ||
Patent #
US 5,280,130 A
Filed 05/22/1992
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Emission based fiber optic sensors for pH and carbon dioxide analysis | ||
Patent #
US 5,280,548 A
Filed 03/11/1993
|
Current Assignee
Ohmeda Pte Limited
|
Original Assignee
BOC Health Care Incorporated
|
Method for manufacturing an electro chemical sensor | ||
Patent #
US 5,310,471 A
Filed 05/26/1993
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Method for assembling package for an active medical device | ||
Patent #
US 5,357,732 A
Filed 05/20/1993
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Electrochemical sensor | ||
Patent #
US 5,354,448 A
Filed 07/20/1993
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Method and device for measuring concentration levels of blood constituents non-invasively | ||
Patent #
US 5,361,758 A
Filed 10/09/1991
|
Current Assignee
Nellcor Puritan Bennett LLC
|
Original Assignee
CME Telemetrix Inc.
|
Dual fiberoptic cell for multiple serum measurements | ||
Patent #
US 5,176,882 A
Filed 12/06/1990
|
Current Assignee
Pelikan Technologies Inc.
|
Original Assignee
HP Inc.
|
Device for preparing a medical sensor for use | ||
Patent #
US 5,188,803 A
Filed 12/01/1988
|
Current Assignee
Abbott Laboratories Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Method for separating coke from a feed mixture containing zirconium and radioactive materials by flotation process | ||
Patent #
US 5,188,809 A
Filed 08/31/1990
|
Current Assignee
Teledyne Instruments Incorporated
|
Original Assignee
Teledyne Instruments Incorporated
|
Method for calibration of a measurement apparatus | ||
Patent #
US 5,185,263 A
Filed 11/04/1991
|
Current Assignee
Avl Medical Instruments AG
|
Original Assignee
Avl Medical Instruments AG
|
Barrier for a connector | ||
Patent #
US 5,230,031 A
Filed 05/22/1992
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Biomedical Sensors Limited
|
Sensor system | ||
Patent #
US 5,093,266 A
Filed 02/27/1989
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Shiley Incorporated
|
Optical sensor for determining at least one parameter in a liquid or gaseous sample | ||
Patent #
US 5,114,676 A
Filed 07/28/1989
|
Current Assignee
AVL AG
|
Original Assignee
AVL AG
|
Chemically reactive pyrenyloxy sulfonic acid dyes | ||
Patent #
US 5,132,432 A
Filed 09/22/1989
|
Current Assignee
Molecular Probes Incorporated
|
Original Assignee
Molecular Probes Incorporated
|
Method for detecting polyhydroxyl compounds | ||
Patent #
US 5,137,833 A
Filed 09/21/1989
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Anthony P. Russell
|
Fiber optic catheter system with fluorometric sensor and integral flexure compensation | ||
Patent #
US 5,012,809 A
Filed 10/10/1986
|
Current Assignee
John E. Shulze
|
Original Assignee
John E. Shulze
|
Intravascular delivery device | ||
Patent #
US 4,906,232 A
Filed 03/01/1988
|
Current Assignee
Abbott Laboratories Incorporated
|
Original Assignee
Abbott Laboratories Incorporated
|
Dual optical fiber device | ||
Patent #
US 4,927,222 A
Filed 06/16/1986
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Shiley Incorporated
|
Micro sensor | ||
Patent #
US 4,798,738 A
Filed 10/10/1986
|
Current Assignee
Terumo Cardiovascular Systems Corporation
|
Original Assignee
Cardiovascular Decisions LLC
|
Multi-channel optical transmission system | ||
Patent #
US 4,822,127 A
Filed 06/16/1986
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Shiley Incorporated
|
Sensor system | ||
Patent #
US 4,833,091 A
Filed 02/06/1987
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Shiley Incorporated
|
Pyrenexulfonic acids useful in fluorescent lipid probes | ||
Patent #
US 4,844,841 A
Filed 09/11/1987
|
Current Assignee
Ernst Koller, Otto S. Wolfbeis
|
Original Assignee
Ernst Koller, Otto S. Wolfbeis
|
Carbon dioxide sensor | ||
Patent #
US 4,851,195 A
Filed 08/17/1987
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
Pfizer Hospital Products Group Inc.
|
Optical probe for measuring pH and oxygen in blood and employing a composite membrane | ||
Patent #
US 4,785,814 A
Filed 08/11/1987
|
Current Assignee
Cordis Corporation
|
Original Assignee
Cordis Corporation
|
Self-calibrating single-use sensing device for clinical chemistry and method of use | ||
Patent #
US 4,654,127 A
Filed 11/27/1985
|
Current Assignee
SENTECH MEDICAL CORPORATION
|
Original Assignee
SENTECH MEDICAL CORPORATION
|
Article for preparing a chemical sensor for use | ||
Patent #
US 4,689,308 A
Filed 05/01/1986
|
Current Assignee
Hospira Incorporated
|
Original Assignee
INTERNATIONAL BIOMEDICS INC.
|
PO.sub.2 /PCO.sub.2 sensor | ||
Patent #
US 4,197,853 A
Filed 07/20/1978
|
Current Assignee
Medtronic Minimed Incorporated
|
Original Assignee
GD Searle LLC
|
Method for monitoring blood glucose levels and elements | ||
Patent #
US 4,240,438 A
Filed 10/02/1978
|
Current Assignee
Wisconsin Alumni Research Foundation
|
Original Assignee
Wisconsin Alumni Research Foundation
|
48 Claims
-
1. A method of calibrating an analyte sensor, the method comprising:
-
providing a vessel containing a first solution, wherein a sensing region of the sensor is in contact with said first solution; obtaining a first calibration signal from the sensor; adding an amount of a second solution into said vessel by means of a syringe, whereupon said sensor produces another calibration signal; and calculating a calibration factor using said first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
-
13. A kit for multipoint calibration of an analyte sensor comprising:
-
a vessel containing a calibration solution, wherein said vessel has a port; and a syringe for delivery of an analyte. - View Dependent Claims (14)
-
-
15. A method of calibrating an analyte sensor, the method comprising:
-
providing a vessel comprising at least two linearly adjacent chambers, wherein each chamber contains a solution, and wherein each chamber is separated from the chamber adjacent to it by a divider such that the solution in each chamber is substantially prevented from mixing with the solution in any other chamber;
wherein a sensing region of the sensor is in contact with the solution in one of the chambers;obtaining a first calibration signal from the sensor; moving the sensing region of the sensor into an adjacent chamber, thereby contacting the sensing region with the solution in said adjacent chamber, whereupon the sensor produces an additional calibration signal; and calculating a calibration factor using said first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor. - View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23)
-
-
24. A method of calibrating an analyte sensor, the method comprising:
-
exposing the sensing region of the sensor to a solution, whereupon the sensor produces a first calibration signal; combining at least one timed-release capsule with said solution, wherein said timed-release capsule contains an analyte; allowing each timed-release capsule to release said analyte contained within it, whereupon the sensor produces another calibration signal; and calculating a calibration factor using said first calibration signal and any additional calibration signals, thereby calibrating said analyte sensor. - View Dependent Claims (25, 26, 27, 28, 29, 30, 31, 32, 33)
-
-
34. A method of calibrating an analyte sensor, the method comprising:
-
obtaining a vessel containing a solution, wherein a sensing region of the sensor is in contact with said solution; and
wherein said vessel comprises at least one rupturable chamber containing an analyte, wherein said analyte is initially substantially separated from said solution;obtaining a first calibration signal from the sensor; rupturing each rupturable chamber, thereby releasing the analyte within it, whereupon the sensor produces another calibration signal; and calculating a calibration factor using said first calibration signal and any additional calibration signals, thereby calibrating said analyte sensor. - View Dependent Claims (35, 36, 37, 38, 39, 40, 41, 42)
-
-
43. A ready-to-calibrate and deploy, sterilized analyte sensor kit, comprising:
-
an analyte sensor comprising an elongate body having an indicator system disposed along a distal portion of the elongate body; and a calibration vessel comprising a sensor port through which the distal portion of the sensor is sealably retained within the vessel until retracted for use, and the vessel further comprising a calibration means in fluid communication with the vessel, wherein the sensor and vessel are pre-assembled, sterilized and sealed within a sterile package, ready for calibration and deployment. - View Dependent Claims (44)
-
-
45. A ready-to-calibrate and deploy, sterilized analyte sensor kit, comprising:
-
an analyte sensor comprising an elongate body having an indicator system disposed along a distal portion of the elongate body and an coupling member configured to interface with an analyte monitor comprising a calibration algorithm; a calibration apparatus comprising a calibration chamber sized to slidably receive and accommodate therein the distal portion of the elongate body of the sensor, an adjustable sealing means for sealing the distal portion within the calibration chamber, an infusion port fluidly coupled to the calibration chamber, and a fluid waste receptacle fluidly coupled to the calibration chamber; and wherein the analyte sensor is slidably engaged within the calibration apparatus, sterilized and sealed within a sterile package, ready for calibration and deployment. - View Dependent Claims (46, 47, 48)
-
1 Specification
This application claims the priority benefit to U.S. Provisional No. 60/917,309 filed May 10, 2007, the entirety of which is hereby incorporated by reference herein.
1. Field of the Invention
An improved method for multipoint calibration of analyte sensors is disclosed in accordance with preferred embodiments of the present invention. In preferred embodiments, the method is adapted to calibrate sensors that monitor the concentration of sugars, i.e., glucose or fructose.
2. Description of the Related Art
Analyte sensors, such as glucose sensors, for detecting and measuring desired characteristics, such as glucose content, of liquid samples are well-known. To assure analyte measurement accuracy, an analyte sensor requires calibration. Errors due to miscalibration of analyte sensors could lead to significant errors in determining the concentration of an analyte of interest. Therefore, prior to use, it is desirable to check a sensor for a linear response to analyte concentration. This is preferably done immediately prior to use.
Thus, there is a significant need for methods that would improve the calibration of analyte sensors. It is therefore desirable to provide a quick, convenient and accurate method of calibrating of an analyte sensor.
In preferred embodiments, the present invention concerns a method for multipoint calibration of an analyte sensor, especially an analyte sensor for determining in vivo, especially sugars, such as glucose or fructose, in physiological media.
A method for multipoint calibration of an analyte sensor is disclosed in accordance with some embodiments of the present invention. The method comprises: providing a vessel containing a first solution, wherein a sensing region of the sensor is in contact with the first solution; obtaining a first calibration signal from the sensor; adding an amount of a second solution into the vessel by means of a syringe, whereupon the sensor produces another calibration signal; and calculating a calibration factor using the first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor.
A method for multipoint calibration of an analyte sensor is disclosed in accordance with another embodiment of the present invention. The method comprises: providing a vessel comprising at least two linearly adjacent chambers, wherein each chamber contains a solution, and wherein each chamber is separated from the chamber adjacent to it by a divider such that the solution in each chamber is substantially prevented from mixing with the solution in any other chamber; wherein a sensing region of the sensor is in contact with the solution in one of the chambers; obtaining a first calibration signal from the sensor; moving the sensing region of the sensor into an adjacent chamber, thereby contacting the sensing region with the solution in the adjacent chamber, whereupon the sensor produces an additional calibration signal; and calculating a calibration factor using the first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor.
A method for multipoint calibration of an analyte sensor is disclosed in accordance with another embodiment of the present invention. The method comprises: exposing the sensing region of the sensor to a solution, whereupon the sensor produces a first calibration signal; combining at least one timed-release capsule with the solution, wherein the timed-release capsule contains an analyte; allowing each timed-release capsule to release the analyte contained within it, whereupon the sensor produces another calibration signal; and calculating a calibration factor using the first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor.
A method for multipoint calibration of an analyte sensor is disclosed in accordance with another embodiment of the present invention. The method comprises: providing a vessel containing a solution, wherein a sensing region of the sensor is in contact with the solution; and wherein the vessel comprises at least one rupturable chamber containing an analyte, wherein the analyte is initially substantially separated from the solution; obtaining a first calibration signal from the sensor; rupturing each rupturable chamber, thereby releasing the analyte within it, whereupon the sensor produces another calibration signal; and calculating a calibration factor using the first calibration signal and any additional calibration signals, thereby calibrating the analyte sensor.
A kit for multipoint calibration of an analyte sensor is disclosed in accordance with another embodiment of the present invention. The kit includes a vessel containing a calibration solution, the vessel having a port for a sensor to access the calibration solution. The kit according to this embodiment of the present invention further includes a syringe for delivery of an analyte.
A ready-to-calibrate and deploy, sterilized analyte sensor kit is disclosed in accordance with another embodiment of the present invention. The kit comprises: an analyte sensor comprising an elongate body having an indicator system disposed along a distal portion of the elongate body; a calibration vessel comprising a sensor port through which the distal portion of the sensor is sealably retained within the vessel until retracted for use, and the vessel further comprising a calibration means in fluid communication with the vessel, wherein the sensor and vessel are pre-assembled, sterilized and sealed within a sterile package, ready for calibration and deployment.
In one variation to the above-described kit, the calibration means comprises a calibration port in fluid communication with the vessel and a syringe comprising a calibration solution fluidly-coupled to the vessel via the calibration port.
A ready-to-calibrate and deploy, sterilized analyte sensor kit is disclosed in accordance with another embodiment. The kit comprises: an analyte sensor comprising an elongate body having an indicator system disposed along a distal portion of the elongate body and an coupling member configured to interface with an analyte monitor comprising a calibration algorithm; a calibration apparatus comprising a calibration chamber sized to slidably receive and accommodate therein the distal portion of the elongate body of the sensor, an adjustable sealing means for sealing the distal portion within the calibration chamber, an infusion port fluidly coupled to the calibration chamber, and a fluid waste receptacle fluidly coupled to the calibration chamber; and wherein the analyte sensor is slidably engaged within the calibration apparatus, sterilized and sealed within a sterile package, ready for calibration and deployment.
A method of calibrating an analyte sensor using the above kit is also disclosed. The method comprises: providing the above analyte sensor kit; providing at least first and second calibration solutions in separate syringes; providing the analyte monitor; coupling the analyte sensor to the analyte monitor via the coupling member and initiating the calibration algorithm; infusing the first calibration solution into the calibration chamber; allowing the sensor to equilibrate; infusing the second calibration solution into the calibration chamber, collecting displaced fluid in the waste receptacle; and allowing the sensor to equilibrate, wherein the calibration algorithm automatically calibrates the sensor.
Throughout the figures, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components or portions of the illustrated embodiments. Moreover, while the subject matter of this application will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments. It is intended that changes and modifications can be made to the described embodiments without departing from the true scope and spirit of the subject invention as defined in part by the appended claims.
Methods and systems for multipoint calibration of an analyte sensor are disclosed in accordance with preferred embodiments of the present invention. Prior to use of an analyte sensor, to ensure accuracy, it is desirable to check the sensor for a linear response to analyte concentration using the calibration methods disclosed herein. This is preferably done immediately prior to use. Various embodiments of apparatuses and procedures described herein will be discussed in terms of glucose sensors. For example, WO 2008/001091A1 describes some solutions to the problem of sensor calibration while maintaining sterility and is incorporated herein in its entirety by reference thereto. However, many aspects of the present invention may find use in other types of analyte sensors.
In order to facilitate an understanding of the disclosed invention, a number of terms are defined below.
The term “calibration” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and it is not to be limited to a special or customized meaning), and refers without limitation to the relationship and/or the process of determining the relationship between the sensor data and corresponding reference data, which may be used to convert sensor data into meaningful values substantially equivalent to the reference.
The term “multipoint calibration” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and it is not to be limited to a special or customized meaning), and refers without limitation to calibration, as defined above, wherein more than one data point is used.
The term “sensor” or “analyte sensor” encompasses any device that can be used to measure the concentration of an analyte, or derivative thereof, of interest. Sensors can be, for example, electrochemical, chemical piezoelectric, thermoelectric, acoustic, or optical. Preferred sensors for detecting blood analytes generally include electrochemical devices and chemical devices. Examples of electrochemical devices include (list examples of such devices).
The term “sensing region” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and it is not to be limited to a special or customized meaning), and refers without limitation to the region of a monitoring device or sensor responsible for the detection of a particular analyte.
The term “vessel” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and it is not to be limited to a special or customized meaning), and refers without limitation to a hollow utensil used as a container, especially for liquids. Examples of vessels suitable for use with the present invention include, but are not limited to, containers, tubes, tubular bodies, tonometers, capsules, tubes, vials, capillary collection devices, and cannulas. In some embodiments, the vessel is a tonometer. In another embodiment, the vessel is a hollow, enclosed tube.
The term “analyte” is used herein to denote any physiological analyte of interest that is a specific substance or component that is being detected and/or measured in a chemical, physical, enzymatic, or optical analysis. A detectable signal (e.g., a chemical signal or electrochemical signal) can be obtained, either directly or indirectly, from such an analyte or derivatives thereof. Furthermore, the terms “analyte” and “substance” are used interchangeably herein, and are intended to have the same meaning, and thus encompass any substance of interest. In preferred embodiments, the analyte is a physiological analyte of interest, for example, glucose, or a chemical that has a physiological action, for example, a drug or pharmacological agent.
Analytes may include naturally occurring substances, artificial substances, metabolites, and/or reaction products. In some embodiments, the analyte for measurement by the sensors and methods disclosed herein is glucose. However, other analytes are contemplated as well.
Although the term “glucose” is used herein below, it is to be understood most polyhydroxyl-containing organic compounds (carbohydrates, 1,2-diols, 1,3-diols and the like) in a solution may used for multipoint calibration of the glucose sensor.
The term “port” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and it is not to be limited to a special or customized meaning), and refers without limitation to an opening or aperture, for example, in the side of a vessel.
The term “substantially” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and it is not to be limited to a special or customized meaning), and refers without limitation to a sufficient amount that provides a desired function.
The term “comprising” as used herein is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.
As used herein, the term “proximal,” as is traditional, refers to the end portion of the apparatus that is closest to the operator, while the term “distal” refers to the end portion that is farthest from the operator.
All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth in the specification and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.
The systems and methods described herein are in connection with multipoint calibration, and in particular with the calibration of a glucose sensor, as further discussed below. In some embodiments, the methods can be used to, calibrate an analyte sensor for monitoring the concentration of a sugar in vitro. In other embodiments, the methods can be used to calibrate an analyte sensor for monitoring the concentration of a sugar in physiological media. In another embodiment, the methods can be used to calibrate an analyte sensor for monitoring in vivo, the concentration of sugars such as glucose or fructose, in physiological media. In another embodiment, the methods can be used to calibrate sensors that monitor the concentration of sugars, i.e., glucose or fructose, in blood while implanted intravascularly. In another embodiment, the analyte sensor is a pH sensor.
In preferred embodiments, the analyte sensor is a glucose sensor. As known to those skilled in the art, there are a variety of sensors used for monitoring the concentration of glucose in a fluid. The sensor(s) to be calibrated by the disclosed methods may be, for example, electrochemical, piezoelectric, thermoelectric, acoustic, or optical. Non-limiting examples of analyte sensors may be found with reference to co-pending applications U.S. application Ser. Nos. 11/671,880, filed on Feb. 6, 2007, entitled “OPTICAL DETERMINATION OF PH AND GLUCOSE”; 60/888,477, filed on Feb. 6, 2007, entitled “OPTICAL SYSTEMS AND METHODS FOR RATIOMETRIC MEASUREMENT OF BLOOD GLUCOSE CONCENTRATION”; and Ser. No. 11/296,898, filed on Dec. 7, 2005, entitled “OPTICAL DETERMINATION OF GLUCOSE USING BORONIC ACID ADDUCTS”; the entire disclosures of which are incorporated herein by reference thereto. In some embodiments, the analyte sensor is an intravascular glucose sensor.
A glucose solution suitable for use in the present invention may have a concentration of glucose, for example, between 0 mg/dL and 2 g/dL, and more preferably between about 0 to 500 mg/dL. In some embodiments, the glucose solution further comprises phosphate buffered saline (PBS), which is comprised of a phosphate buffer and sodium chloride. The PBS is used to balance the osmolarity of the glucose solution to a physiological osmolarity level and can be used to adjust the pH to between 6 to 8.
The calibration methods disclosed can be used with any calculation method useful for determining a calibration factor. The calculation of the calibration factor can be obtained, for example, using linear regression, least squares linear regression, non-linear regression, or a non-linear regression technique.
In some embodiments, the first solution does not contain glucose. The first solution can be, for example, water or PBS with a pH between 6 to 8. In another embodiment, the first solution is a glucose solution. In some embodiments, the second solution is a glucose solution. In another embodiment, the second solution does not contain glucose. The concentration of glucose in the first and second solutions should differ from each other. For example, in embodiments where the first solution does not contain glucose, it is desirable for the second solution to contain glucose. The addition of the second solution to the first solution changes the glucose concentration of the solution in contact with the sensor. The sensor produces a calibration signal in response to the new glucose concentration.
In embodiments where the analyte sensor is a pH sensor, the second solution may be an acid. Alternatively, the second solution may be a base.
The syringe used to add the second solution can have stops for adding a premeasured amount of the second solution. The stops allow an operator to conveniently add a known quantity of the second solution to the vessel. For example, the syringe may have stops for delivering 1 ml increments of the second solution. The syringe can have any number of stops, for example, from one stop to ten stops. Preferably, the syringe has three stops. In some embodiments, the syringe is pre-filled with the second solution. In another embodiment, the operator fills the syringe with the second solution immediately prior to calibration.
In some embodiments, the second solution is added to the solution in the vessel two times. After each addition, a calibration signal is produced by the sensor, and the calibration factor is calculated using the first calibration signal and the two additional calibration signals. One to four data points, and preferably two to three data points, can be used for calibration of the sensor.
In some embodiments, the sensing region of the sensor is inserted through a port 70 of a vessel 40, thereby contacting the first solution in the vessel.
In some embodiments, additional syringes containing additional solutions may be used to vary the concentration of analyte inside the vessel. In some embodiments, the additional syringes are inserted through the first port 65. The first port 65 may be adapted to accept any number of syringes.
In some embodiments, the step of moving the sensing region is carried out by retracting the sensor into an adjacent chamber. In another embodiment, the step of moving the sensing region is carried out by advancing the sensor into an adjacent chamber. The step of moving the sensing region into an adjacent chamber can be repeated any number of times. In some embodiments, the step of moving the sensing region is carried out at least twice. In another embodiment, the step of moving the sensing region is carried out three times.
The vessel may comprise any number of chambers greater than one. In some embodiments, the vessel comprises three chambers. In another embodiment, the vessel comprises four chambers.
The solution in each chamber may or may not contain an analyte. In some embodiments, the solution in the chamber is a glucose solution. In embodiments where the solution is a glucose solution, the analyte is glucose. In some embodiments, the solution in each chamber has a glucose concentration of, for example, between 0 mg/dL and 2 g/dL, and more preferably between about 0 to 500 mg/dL. In some embodiments, the glucose solution further comprises phosphate buffered saline (PBS), which is comprised of a phosphate buffer and sodium chloride. The PBS is used to balance the osmolarity of the glucose solution to a physiological osmolarity level and can be used to adjust the pH to between 6 to 8.
Preferably, the concentration of analyte in the solution in each chamber differs from the concentration of analyte in the solution in any other chamber. In some embodiments, the vessel comprises three chambers: a first chamber, a middle chamber, and a last chamber, wherein each chamber contains a solution having a different analyte concentration. In some embodiments, the analyte concentration of the solution increases as the sensing region is moved proximally. In some embodiments, the first chamber does not contain analyte. In some embodiments, the analyte concentration of the solution in the first chamber is 400 mg/dL, the analyte concentration of the solution in the middle chamber is 100 mg/dL, and the analyte concentration of the solution in the last chamber is 0 mg/dL. In another embodiment, the glucose concentration of the solution in the first chamber is 0 mg/dL, the glucose concentration of the solution in the middle chamber is 400 mg/dL, and the glucose concentration of the solution in the last chamber is 100 mg/dL.
In some embodiments, the sensing region 10 of the analyte sensor 20 is inserted through the port 70 of a vessel 80.
In some embodiments, the analyte sensor is a glucose sensor. In an embodiment wherein a glucose sensor is being calibrated the analyte contained in the timed-release capsule is glucose. The glucose exists at a concentration of, for example, between 0 mg/dL and 2 g/dL, and more preferably between about 0 to 500 mg/dL.
The solution may be any suitable for calibrating the analyte sensor. The solution may be, for example, comprised of a phosphate buffer or PBS.
A timed-release capsule suitable for use in the present invention can be, for example, a capsule containing a reservoir of analyte and having a degradable membrane or barrier that can dissolve in a solvent, as discussed more fully below. Such a solvent can be, for example, water. The capsule can have a variety of configurations, including the configurations depicted in
The timed-release capsule can take any amount of time to release the analyte contained within it. The timed-release can take, for example, between 10 seconds and 60 minutes to release the analyte contained within it.
The timed-release capsule may comprise a degradable membrane 170. In some embodiments, the dissolution of the degradable membrane is initiated when the timed-release capsule is combined with the calibration solution. In some embodiments, the degradable membrane has a dissolution rate proportional to the thickness of the membrane. Thus, in some embodiments, the time it takes for the analyte to be released is controlled by the thickness of the membrane/barrier. The thicker the membrane or barrier, the longer it takes the membrane or barrier to degrade, and the longer it takes the analyte to be released. Where more than one timed-release capsule is combined with the solution, the timed-release capsules may have different dissolution rates. Alternatively, the timed-release capsules may have the same dissolution rate.
At least one timed-release capsule is combined with the solution, and preferably at least two timed-release capsules are combined with the solution. In some embodiments, the method comprises three timed-release capsules. In other embodiments, the method comprises one to four timed-release capsules, and more preferably two to three timed-release capsules. In embodiments where more than one timed-release capsule is combined with the calibration solution, each timed-release capsule can take either a different or the same amount of time as the other timed-release capsule(s) to release the analyte contained within it. Preferably, the timed-release capsules have different release times. The timed-release capsules can be combined with the calibration solution simultaneously, or at different times. When multiple timed-release capsules are simultaneously combined with the calibration solution and each has a distinct and known time to release, the change in the analyte concentration over time can be predicted. Multiple calibration points can thus be generated at known time intervals.
In some embodiments, the analyte sensor is a glucose sensor. The glucose sensor may be, for example, an intravascular glucose sensor. Preferably, the analyte is glucose. The glucose in the rupturable chamber may exist at a concentration of, for example, between 0 mg/dL and 2 g/dL, and preferably between 0 to 500 mg/dL.
The solution contained in the vessel may be any solution suitable for calibrating the analyte sensor. The solution may be, for example, comprised of phosphate buffer or PBS.
The rupturable chamber can exist in a variety of configurations. A rupturable chamber suitable for use in the present invention can be, for example, a rotatable chamber. Such a rotatable chamber may be ruptured by rotating 190 the rupturable chamber, thereby releasing the analyte. The rotatable chamber may comprise a knob 195 which an operator can grasp and twist, thereby rotating the chamber.
Rotation of the rupturable chamber may rupture the chamber by, for example, shearing. Alternatively, the rupturable chamber may, for example, comprise a valve 200, wherein the valve remains in a closed position until the rupturable chamber is rotated, whereupon the valve opens, thereby releasing the analyte. In another embodiment, the rupturable chamber is ruptured by exerting pressure on the rupturable chamber, thereby rupturing the chamber and releasing the analyte. In another embodiment, the vessel is rotated 210, thereby rotating the rupturable chamber(s) and releasing the analyte within.
In some embodiments, it is desirable to sterilize an analyte sensor. In some embodiments, it is desirable to sterilize an analyte sensor in conjunction with a calibration system. The calibration systems described may be sterilized by a variety of methods. Once sterilized, calibration of the analyte sensor can be carried out under sterile conditions, and the calibration system may be kept sterile indefinitely. The analyte sensor maybe sterilized by, for example, autoclaving or ethylene oxide.
In other embodiments, the valve 220 may be disengaged. Disengagement of the valve may be used, for example, during ethylene oxide sterilization. During ethylene oxide sterilization, the ethylene oxide gas requires access to the sensor. Disengagement of the valve permits the ethylene oxide gas to gain access to the sensor and sterilize the sensor surfaces.
In some embodiments, the valve 612 is a Touhy-Borst valve that provides a seal around the sensor 602 and clamps the sensor 602 in place. A first calibration solution can be introduced into the system 600 via the side port 614. After a measurement has been taken, the calibration solution can be drained into the bag 618 by actuating the stopcock 616 from a closed position to an open position. The absorption sponge 620 in the bag 618 facilitates drainage of the calibration solution from the sensor calibration chamber 604. After the calibration solution is drained, the stopcock 616 can closed and a second calibration solution can be introduced. Additional calibration solutions can be introduced by draining the solution into the bag 618 before introduction of the next solution. Alternatively, in some embodiments, the introduction of the next calibration solution is used to push the previous calibration solution into the bag 618. In these embodiments, the stopcock 616 is open during the introduction of the next calibration solution.
The calibration chamber 604 has a heater 700 for heating the calibration solution before calibration measurements are taken. The calibration solution can be heated to approximately the body temperature of the patient or test subject, i.e., 37 degrees Celsius for a human patient. In some embodiments, the calibration solution can be heated to a temperature that is lower or higher than 37 degrees Celsius. For example, if the patient'"'"'s body temperature is less than 37 degrees Celsius, the calibration solution can be heated to match the patient'"'"'s body temperature. In addition, if the patient'"'"'s peripheral body temperature is lower than the patient'"'"'s core body temperature and the glucose measure will be taken at the peripheral location, the calibration solution can be heated to match the patient'"'"'s lower peripheral body temperature. Alternatively, if the patient has a body temperature that is greater than 37 degrees Celsius, for example as a result of an infection, the calibration solution can be heated to a temperature greater than 37 degrees Celsius to match the patient'"'"'s body temperature.
The heater 700 can comprise a resistive heating element that is coiled around or within the calibration chamber 604. In some embodiments the heater 700 and heating element may be separate from the calibration chamber 604 and can be brought into contact with the calibration chamber 604 when heating of the calibration chamber 604 is required. Separating the heater 700 from the calibration chamber 604 allows the heater 700 to be reused. In some embodiment, the heater 700 is wrapped around the calibration chamber 604. In other embodiments, the calibration chamber 604 is inserted into the heater 700. In some embodiments, the heater 700 extends along a substantial portion of the calibration chamber 604, thereby facilitating rapid and uniform heating of the calibration fluid.
In some embodiments, the heater 700 can be powered via a power line 702 that can be connected to a glucose monitor 704, which can also be connected to the glucose sensor 602 via a glucose sensor line 706 and a glucose sensor connection interface 708. Although the glucose monitor 704 and glucose sensor line 706 can be considered a part of the glucose calibration system 600, in some embodiments, the glucose monitor 704 and glucose sensor line 706 are separate from the glucose calibration system 600. In some embodiments, the glucose monitor 704 comprises a heater controller for controlling the temperature and heating rate of the heater 700, and the user can select a temperature and initiate heating using the glucose monitor 704. The power line 702 can also connect the heater controller with the heater 700. In other embodiments, the heater 700 can comprise a heater controller such that a user can directly select a temperature and initiating heating on the heater itself. In some embodiments where the heater 700 comprises a heater controller, the heater controller can be connected to the glucose monitor 704 such that the glucose monitor 704 can provide basic instructions to the heater controller, such as on/off instructions and the desired temperature. In some embodiments, the heater 700 can be supplied with power from a source independent of the glucose monitor 704. For example, in some embodiments, the heater 700 can be connected to a battery or plugged into a conventional wall socket.
Pre-heating the glucose calibration fluid can be important when the glucose sensing technology is temperature sensitive or temperature dependent. By calibrating the glucose sensor 602 at, for example, 37 degrees Celsius to match the patient'"'"'s body temperature, the accuracy of in-vivo glucose measurements can be improved. The glucose monitor 704 can have a display 710 for displaying instructions to the user for performing the calibration procedure. In addition, the display 710 can display the status of the calibration procedure, including the time to complete each step, the time remaining for each step, and the results of each step. For example, the display 710 can show the temperature of the calibration fluid and can show the results of each of the glucose measurements.
The temperature of the calibration solution can be monitored by a temperature sensor, such as a thermocouple, thermistor, resistance temperature detector, or any other suitable temperature sensor. The temperature sensor can be part of or included with the glucose sensor (not shown), or the temperature sensor can be separate from the glucose sensor and reside in or on the calibration chamber 604 with the heater 700. In either case, the temperature sensor can be powered by and send data to the glucose monitor 704 via the power line 702 or the glucose sensor line 706 or via an independent power line. In other embodiments, the temperature sensor can be in communication with and powered by the heater 700 and/or heater controller.
The proximal end 606 of the calibration chamber 604 can be attached to a 3-way connector 712 that is also attached to a fill line 714 and a valve 716, which can be, for example, a Touhy-Borst valve. The fill line 714 can terminate in an infusion port 718. The glucose sensor 602 can be introduced into the calibration chamber 604 via the valve 716. Calibration solution can be introduced into the calibration chamber 604 via the infusion port 718 of the fill line 714 using, for example, a syringe with or without a hypodermic needle. In some embodiments, the location of the fill line 714 and bag 618 can be switched. If the location of the fill line 714 and bag 618 are switched, the one-way valve 616 generally remains attached to the bag 618.
To calibrate the glucose sensor 602, calibration solution with a known glucose concentration is introduced into the calibration chamber 604 via the infusion port 718 of the fill line 714. The glucose sensor 602 is introduced into the calibration chamber 604 via the valve 716 attached to the 3-way connector 712. The glucose sensor 602 can be introduced into the calibration chamber 604 either before or after the calibration solution is introduced into the calibration chamber 604. The power line 702 and glucose sensor 602 are attached to the glucose monitor 704 and this step can be done either before or after the calibration fluid is introduced into the calibration chamber 604. The calibration solution is heated by the heater 700 to about the patient'"'"'s body temperature, which generally is about 37 degrees Celsius. Once the calibration solution is heated to the target temperature, a first calibration measurement can be taken. If a second calibration measurement is desired, the first calibration solution can be drained and/or flushed into the bag 618 using, for example, a second calibration solution, which has a different glucose concentration than the first calibration solution. Sufficient second calibration solution can be used to flush the first solution to ensure that substantially all of the first calibration fluid is flushed into the bag 618. Once the second solution has replaced the first solution in the calibration chamber 604, the heater 700 can be used to heat the second solution to the patient'"'"'s body temperature. Once the second solution is heated to the target temperature, a second calibration measurement can be taken. If additional calibration measurements are desired, for example a third calibration measurement, the steps of draining and/or flushing the previous calibration solution with the next calibration solution and then heating the next calibration solution before taking the calibration measurement can be repeated.
The calibration chamber 604 has a heater 700 for heating the calibration solution before calibration measurements are taken. The heater 700 can comprise a resistive heating element that is coiled around or within the calibration chamber 604. In some embodiments the heater 700 and heating element may be separate from the calibration chamber 604 and can be brought into contact with the calibration chamber 604 when heating of the calibration chamber 604 is required. In some embodiments, the heater 700 extends along a substantial portion of the calibration chamber 604, thereby facilitating rapid and uniform heating of the calibration fluid.
In some embodiments, the heater 700 can be powered via a power line 702 that can be connected to a glucose monitor 704, which can also be connected to the glucose sensor 602 via a glucose sensor line 706 and a glucose sensor connection interface 708. The glucose monitor 704 can have a display 710 for displaying instructions to the user for performing the calibration procedure. In addition, the display 710 can display the status of the calibration procedure, including the time to complete each step, the time remaining for each step, and the results of each step. For example, the display 710 can show the temperature of the calibration fluid and can show the results of each of the glucose measurements. Although the glucose monitor 704 and glucose sensor line 706 can be considered a part of the glucose calibration system 600, in some embodiments, the glucose monitor 704 and glucose sensor line 706 are separate from the glucose calibration system 600.
The proximal end 606 of the calibration chamber 604 can be attached to a connector 800 that matches the connectors used in an arterial line or central venous line. The glucose sensor 602 can have a corresponding connector 802 designed to be attached to an arterial line or central venous line connector. By using arterial line or central venous line connectors, the glucose sensor 602 can be seamlessly attached to both a calibration system 600 and then to an arterial line or central venous line after the glucose sensor 602 has been calibrated.
The corresponding connector 802 is attached to the distal end a protective sleeve 804. The proximal end of the protective sleeve can include both an infusion port 718 and a first valve 806, such as a Touhy-Borst valve. A second valve 808, such as a Touhy-Borst valve, can be placed proximally the first valve 806, with a slidable sheath 810 positioned therebetween. When both the first valve 806 and the second valve 808 are opened, the slidable sheath 810 can be inserted into the protective sleeve 804, thereby advancing the glucose sensor 602 into the calibration chamber 604. When calibration is completed, the slidable sheath 810 can be withdrawn from the protective sleeve 804, thereby withdrawing the glucose sensor 602 from the calibration chamber 604 and back into the protective sleeve 804. Insertion of the glucose sensor 604 through the arterial line or the central venous line and into the patient'"'"'s vasculature can be accomplished in the same manner. The protective sleeve 804 provides protection to the glucose sensor 602 while the slidable sheath 810 allows clamping of the glucose sensor 602 by the first valve 806 and the second valve 808 on less sensitive portions of the glucose sensor 602.
To calibrate the glucose sensor 602, the connector 800 and the corresponding connector 802 of the glucose sensor 602 are connected together. Calibration solution with a known glucose concentration is introduced into the calibration chamber 604 via the infusion port 718 of the protective sleeve 804. For example, the first calibration solution can have a glucose concentration of 0 mg/dL. The glucose sensor 602 is introduced into the calibration chamber 604 via the connection between the connector 800 and corresponding connector 802. The glucose sensor 602 can be introduced into the calibration chamber 604 either before or after the calibration solution is introduced into the calibration chamber 604. The power line 702 and glucose sensor 602 are attached to the glucose monitor 704 and this step can be done either before or after the calibration fluid is introduced into the calibration chamber 604. The calibration solution is heated by the heater 700 to about the patient'"'"'s body temperature, which generally is about 37 degrees Celsius. Once the calibration solution is heated to the target temperature, a first calibration measurement can be taken. If a second calibration measurement is desired, the first calibration solution can be drained and/or flushed into the bag 618 using, for example, a second calibration solution, which has a different glucose concentration than the first calibration solution. For example, the second calibration solution can have a glucose concentration of about 400 mg/dL. Sufficient second calibration solution can be used to flush the first solution to ensure that substantially all of the first calibration fluid is flushed into the bag 618. Once the second solution has replaced the first solution in the calibration chamber 604, the heater 700 can be used to heat the second solution to the patient'"'"'s body temperature. Once the second solution is heated to the target temperature, a second calibration measurement can be taken. If additional calibration measurements are desired, for example a third calibration measurement, the steps of draining and/or flushing the previous calibration solution with the next calibration solution and then heating the next calibration solution before taking the calibration measurement can be repeated. For example, the third calibration solution can have a glucose concentration of about 100 mg/dL. In some embodiments, the calibration procedure can be shortened by calibrating first at 0 mg/dL, then at the highest level, e.g., 400 mg/dL, and then at an intermediate level, e.g., 100 mg/dL. This order can reduce calibration time where analyte detection involves reversible binding kinetics between the analyte and detector.
In some embodiments, the infusion port 718 can be switched with the one-way valve 616 and bag 618. In these embodiments, the infusion port 718 is attached to the calibration chamber 604 with or without an infusion line. The one-way valve 616 can be attached to proximal portion of the protective sleeve 804 and the bag 618 can be attached to the one-way valve.
The embodiments described above, such as the embodiments shown in
The various devices, methods and techniques described above provide a number of ways to carry out the invention. Of course, it is to be understood that not necessarily all objectives or advantages described may be achieved in accordance with any particular embodiment described herein. Also, although the invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof. Accordingly, the invention is not intended to be limited by the specific disclosures of preferred embodiments herein.